SonoCT,Xres新技术对肝癌与肝血管瘤诊断的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的探讨实时复合成像(SonoCT)、极端分辨率(Xres)新技术对肝癌与肝血管瘤诊断的临床应用价值。
    方法将80例肝癌(HCC)与肝血管瘤(HHE)分成两组,经SonoCT、Xres图像了解其内部、周边、后方图像特征,并与普通超声图像进行对比。
    结果
    一、肝癌与肝血管瘤SonoCT、Xres图像与普通超声图像对比:
    (一)肝血管瘤SonoCT、Xres图像与普通超声图像对比:1、普通超声显示23.8%HHE边界清楚,21.4%HHE内部细微结构显示清晰。SonoCT、Xres图像显示85.7%HHE边界清楚,90.5%HHE内部细微结构显示清晰,两组图像对肝血管瘤边界及内部细微结构的显示,差异有显著性,P<0.05。2、SonoCT、Xres图像对肝血管瘤内部及周边特征的显示均较普通超声清晰,提供了更多的诊断信息。
    (二)肝癌SonoCT、Xres图像与普通超声图像对比:1、普通超声显示12.2%的肝癌边界清楚,10.2%内部细微结构显示清晰。SonoCT、Xres图像显示93.9%肝癌边界清楚,95.9%内部细微结构显示清晰,两组图像对肝癌边界及内部细微结构的显示,差异有显著性,P<0.05。2、肝癌周边特征通过SonoCT、Xres图像与普通超声两组图像比较,差异有显著性,P<0.05。SonoCT、Xres图像较普通超声提供了更丰富的内部特征信息。
Hepatic carcinoma (HCC) and hepatic hemangioma (HHE) arethe common hepatic space-occupying lesions. But their nature isdifferent. HCC has high rate in degistive systematic malignant tumorin our country, it also has high case fatalty rate and the prognosis of itis bad .So giving diagnosis earlier and therapy earlier is the key ofimproving prognosis and raising survival rate. But as we all know thatHCC is benigh tumor of liver and the growth of it is slow, it does harmto health little. Therefore, the identification of HCC and HHE is veryimport. It has vital clinical significance for treatment and prognosis.
     The recent coming years, with the development of ultrasonicmedical technology, especially, the applications of new outcomes ofcomputer technology, it improves the accuracy of diagnosis obviously.And it offers valuable diagnosis evidence. SonoCT and Xres are twoquantum jumps in two dimensional imaging. Compared with commonultrasound, SonoCT can gain 9 more times picture information thancommon ultrasonic scanning. So it improves the quality of ultrasonicpicture. Such as speckle, multiple reflection, noise, flare, attenuation,refraction shadowing and so on, those artificial imaging are cancelled.Xres technology improves picture quality by carrying out real-timeanalysis of pixel geometry in a mess disposed. It displays tissuetexture of human body extreme excellent and raises detecting rategreatly. This research is about application of SonoCT and Xres
    technologies in identifications between hepatic carcinomas andhepatic hemangimoas. It makes border and internal structure displaymore clearly, and it strengthens minute resolution in tumor, it gainsvarious tissue information that can't obtain in common ultrasound. Soit can provide more reliable evidence for diagnosis and raisediagnostic accuracy.Imaging characteristics of hepatic carcinoma and hepatichemangioma in SonoCT and Xres:1 hemangioma imagingcharacteristics: the border strong echo band is typical. Especially, thespecificity of hypo echo small hemangioma is high. The diagnosticvalue is similar to acoustic halo in hepatic carcinoma. Circumferentiafissure signe is the characteristic appearance to HHE. The twocharacter play an important role in diagnosis of hemangimoa.Posterior enhancement effect much more displayed in irradiation. Inaddition, blood sinus echo displayed clearly, the number is much more.While,we can see fiber interval, small vessels, and strip shape hypoecho so on images. 2. imaging characteristics of hepatic carcinoma:the acoustic halo was the typical performence in hepatic carcinoma. Inmy research, the halo can appear sentus, serration or wave changes.And we can see, the outside of halo had strong echo zone surroundingdiscontinuous or continual. Posterior enhancement effect much moredisplayed in endoduction. There were some signs in hepatic carcinoma,such as strip shape, small fiber zone, blood vessel desected and so on.The contrast of SonoCT、Xres images between hepatic carcinoma and
    hepatic hemangioma: 1.the ring of strong echo at the hemangioma'sborder;2.the halo:the characteristic appearance of hepatic carcinoma.3.Strip shape hypo echo was confirmed vessel structure intratumoral.Hepatic carcinomas mostly show off courser twisted and irregularstrip shape hypo echo. Because of local small vascular engorgement,stasis, expansion, hepatic hemangiomas almost show normal vesselecho of courser straight. 4. Hepatic carcinoma and hemangioma allcan be seen posterior enhancement effect. Hepatic carcinoma almostshowed off adduction, but hemangioma mostly showed off irradiationor verticality.Compared with the image of common ultrasound, the result ofSonoCT、Xres in hepatic carcinoma and hepatic hemangioma asfollowing: 1. The comparison between common ultrasound andSonoCT、Xres images in hepatic hemangioma: ①the images ofSonoCT、Xres displayed more clearly than common ultrasoundimages, and SonoCT、Xres showed off the numbers of Circumferentiafissure signe more than common ultrasound. The difference issignificant in two sets. P 0.05.②the images of SonoCT、Xresdisplayed more information than common ultrasound in hemangioma.2. The comparison between common ultrasound and SonoCT、Xresimages in hepatic carcinoma:①the images of SonoCT、Xres was moreclearly than common ultrasound towardsing the halo and the strongecho zone outside. The difference is significant in two sets. P 0.05.②the images of SonoCT、Xres displayed more information than
    common ultrasound in hepatic carcinoma.Three-dimensional color power angiography (3D-CPA) imagingcharacteristics: According to the numbers vessels in tumor, theaffection was divided into hypo-vessel and hyper-vessel. Hepaticcarcinomas always showed off hyper-vessel. It's appearance of3D-CPA was complicated and various. It displayed such as branchshape, reticulate, radiate and so on. Hemangiomas always showed offhypo-vessel.SonoCT combined with Xres are superior to the commonultrasound in the two dimensional ultrasonic diagnosis betweenhepatic carcinoma and hemangioma. They can not only gain morevarious tissue information than common ultrasound, but also cancancel artifacts such as speckle noise, echo attenuation and so on.They provide reliable evidence and raised accuracy of diagnosis. Theyare safe, convenient, reproducibale and so on, at the same time theyavoid unnecessary wound and medical cost.
引文
1. 吴孟超. 原发性肝癌的诊断和治疗进展 [J]. 中华外科杂志, 1998,36:515-518.
    2. 张晶, 董宝玮, 梁萍等: 原发性肝癌超声鉴别诊断的病理基础. 中华超声影像杂志, 2001,10(7):410-413.
    3. Ashida C, Traughber PD, Cook PS. computed tomography of hepatic cavernous hemangioma [J]. J Comput Assist Tomogr, 1987,11:455-463.
    4. 徐智章. 医学超声对肝癌诊断治疗的研究进展. 中华超声医学杂志, 1999,(8)4:197-199.
    5. Lee JY, Choi BI, Han JK, LeeJK, Kim SH. State-of-the-art ultrasonography of hepatocellular carcinoma.J Radiology, 2006,Jan28.
    6. Entrekin R, Jackson P Jagpo JR et al. Real time spatial imaging in breast ultrasound:techmology and early clinical experience. Medicamundi, 1999,43(3):35-43.
    7. Adler DD. Ultrasound of benign breast conditions. Semin Ultrasound CT MR, 1989,10:106-118.
    8. Fomage BD. Fibroadenoma of the breast sonographic appearance. Radiology, 1989,172,671-675.
    9. KwakJK, Kim EK, You JK, Oh KK. Variable breast conditions: comparison of conventional and real-time compound ultrasonography. [J]. Ultrasound Med. 2004 Jan;23(1):85-96.
    10. 武忠弼. 病理学 (第四版). 北京: 人民卫生出版社,1996.
    11. Tanaka S, Kitamura T, Fujita M, et al Color Doppler flow imaging of liver tumors AJR, 1993,169:509-514.
    12. 曾燕荣, 赵玉珍. 肝癌血供的多普勒超声研究进展 [J]. 中国医学影像技术, 2002,18(10):1081-1083.
    13. Chou YH. Application of amplitude ultrasonic angiography in the abdonmen J Med Ultrasound, 1994,2:5.
    14. Choi BI, Kim TK, Han JK, et al Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors [J]. Radiology, 1996,200(1):55-58.
    15. Faneli M, Locopo N, Guttuso D, et al. Assessment of tumor vascularization immunohist chemical and non-invasive methods. In [J]. Biol Markers, 1999,10:218-231.
    16. 卓德斌, 陈萍, 张智坚等. 肝癌射频治疗后超声多普勒技术对肝脏及肿瘤内血流动力学变化的评价. 中国微创外科杂志. 2005,4(5)271-273.
    17. Tsai PY, Chang CH, Chang FM. Prenatal diagnosis of the fetal frontal encephalocete by three-dimensional ultrasound Prenat Diagn. 2006 Mar 27;26(4):378-380.
    18. Kalache KD, Eder K, Esser T, Proquitte H, et al. Three -dimensional ultrasonographic reslicing of the fetal brain to assist prenatal diagnosis central nervous system anomalies. [J] Ultrasound Med.2006 Apr;25(4):509-14.
    19. Testa AC, Ajossa S, Ferrandina G, et al. Does quantitative analysis of three-dimensional pelvic solid tumors. A preliminary study. Ultrasound Obstet Gvnecol2005 Jul;26(1):67-72.
    20. Testa AC, Ferrandina G, Distegano M, et al. Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma. Ultrasound Obstet Gvnecol.2004 Sep;24 (4):445-52.
    21. Von Herbay A, Haussinger D. Abdominal three-dimensional power Doppler imaging J Ultrasound M ed 2001;151-157.
    22. Fleischer AC. Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications J Ultrasound Med 2000;19:55-61.
    23. Liang JD Yand PM Liang PC, Huang GT, Sheu JC, Chen DS. Three-dimensional power Doppler ultrasonography for demonstrating associated arteries of hepatocellular carcinoma. J Formos Med Assoc. 2003 Jun;102(6):367-74.
    24. 刘丽, 徐辉雄, 吕明德等. 原发性肝癌三维能量多普勒显像及血管造影的相关性. 中国超声医学杂志 2003,19:606-609.
    25. 那桂萍, 周晓东等. SonoCT 技术诊断甲状腺肿块的初步应用. 2001,10(6);356-358.
    26. Starros A T, Thikman D, Rapp CY, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions, Radiology, 1995,1996(1):123-124.
    27. 周永昌, 郭万学主编, 超声医学. 第三版 北京: 科学技术文献出版社,. 1998,392-397.
    28. 陈敏华主编, 消化系疾病超声学. 北京: 北京出版社,2002.
    29. Narayanan G, Yag DC, Tai KC, et al. Giant hepatic hemangioma studied with intraveaous total body arteriography technique a case report, [J] Clin NuclMed, 1996,39(6):456-459.
    30. Paul M, Silverman, Robert K Zeman. CT and MRI of the liver and biliary system [M]. New York: Chur Living stone Inc, 1990,98-103.
    31. 肝血管瘤的诊断及介入治疗. 吴海江, 崔宁, 董超等. 中国误诊学杂志. 2005,10(5)13;2487-2488.
    32. 梁英锐, 丁濂等主编. 现代肝脏病理学. 天津: 科学技术出版社, 1998.320.
    33. Janaka S, Kitamura T, Fujita M, et al. Color Doppler flow imaging of liver tumors. AJR 1993,169:509-514.
    34. Shimanoto K, Sakuma S, Ishigaki T, et al. Intratumoral blood flow: evalution with color Doppler echography. Radiology1.987, 165:683-688.
    35. Dekme S, KnoppMW. Non-invasive vascular imaging: assessing tumor vascularity [J]. EurRadiol,1998;8(4):517-527.
    36. Taylor KIW, Ramos I, Morse S, et al. Focal liver masses: differential diagnosis with pulsed Doppler US [J]. Radiology, 1987,(16)4:643-644.
    37. Xu HX, Yin XY, Lu MD, et al. Estination of liver tumor volume using athree-dimensional ultrasound volumetric sustem. Ultrsound Med Biol, 2003;29:839-846.
    38. Xu HX, Yin XY, Lu MD, et al Comparison of three-and two-dimensional sonography in diagnosis of gallbladder diseases: preliminary experience J Ultrasound M ed, 2003;22:181-191.
    39. Xu HX, Zhang QP, Lu MD, et al. Comparison of two-dimensional andthree-dimensional sonography in evaluating fetal malfomations J Clin Ultrasound, 2002;30:515-525.
    40. Xu HX, Lu MD, Zhou YQ, et al. Three-dimensional gray scale volume rendering of the liverz: preliminary clinical experience J Ultrasound M ed, 2002;21:961-970.
    41. Carson PL, Fowlkes JB, Roubidoux MA, et al. 3-D color Doppler imaging quantification of breast masses Ultrasound Med Biol 1998;24:945-952.
    42. Downey DB Fenster A. Vascular imaging with a three-dimensional power Doppler system. AJR Am J Roentgenol 1995;165:665-668.
    43. Von Herbay A, Haussinger D. Abdominal three-dimensional power Doppler imaging J Ultrasound M ed 2001;20:151-157.
    44. 刘世萍, 杨通明, 唐石初等. 肝癌的彩色多普勒及三维血流能量成像与肝动脉血管造影对比研究. 中国超声医学杂志, 2000年, 第 16 卷, 第二期.